SCP-348
Safe
✓
high confidence
SCP-348
Expected annual
$149K
One-time setup
$153K
Annual recurring
$146K
Personnel
3
First-year one-time setup and optional research startup (~$153k) dominate initial costs; ongoing annual costs are modest but driven mainly by staff wages, oversight, sample testing and liability/overhead (~$138k/yr).
One-Time Capital Costs
Total: $153K
Annual Recurring Costs
Total: $146K/yr
Cost Scenarios
📊
Baseline
(baseline)
$146K/yr
Normal year with routine oversight, occasional testing, and no major incidents or trials.
routine testing cadence
no incidents
no formal trial initiation
🚨
Minor Incident
$143K/yr
Small contamination, spill, or localized adverse subject reaction requiring extra testing, disposal, and temporary response.
minor contamination
unexpected adverse effect in subject
small-scale equipment failure
🚨
Research Trial
$288K/yr
Foundation initiates a pilot clinical research/trial (protocol launch year) to formally quantify therapeutic effects.
formal pilot trial start
multi-site IRB approvals
expanded clinical recruitment
🚨
Major Breach
$188K/yr
Significant containment/operational failure or public exposure requiring legal response, extra security, and remediation.
public disclosure
major contamination requiring remediation
large-scale legal/regulatory action
Personnel
3 total
| Role | Count | Notes |
|---|---|---|
| Administrative Staff | 1 | [#6] Part-time admin to process authorizations, scheduling and logs (covered in staff wages). |
| Research Scientist | 1 | [#13, #14, #25] Research/analysis allocation for planning and running small studies and liaising with labs (pro-rated FTE). |
| Security Officer / MTF Agent | 1 | [#2, #17, #26] Security/onsite custody to control access to the locker and handle transport/security logistics (pro-rated allocation). |
Confidence Notes
Analyst notes provide detailed line-item ranges and likely test frequencies; SCP-348 is Safe and low-footprint so baseline recurring costs are well constrained and optional research scenarios are clearly scoped.